J-B Micol
Overview
Explore the profile of J-B Micol including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
197
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Danlos F, Papo M, Micol J
Rev Med Interne
. 2019 May;
40(10):684-692.
PMID: 31126662
Clonal hematopoiesis of undetermined significance or CHIP describes the identification, in individuals without hematologic disease, of one or more somatic mutations in hematopoietic cells. These mutations, detected by high-throughput genes...
2.
Duchmann M, Braun T, Micol J, Platzbecker U, Park S, Pilorge S, et al.
Blood Cancer J
. 2017 May;
7(5):e562.
PMID: 28498370
No abstract available.
3.
Annereau M, Willekens C, El Halabi L, Chahine C, Saada V, Auger N, et al.
Leuk Res
. 2017 Jan;
55:58-64.
PMID: 28131982
Background: Patients diagnosed with therapy-related myeloid neoplasms (TRMN) with concomitant active neoplastic disorder (CAND) are usually proposed for best supportive care (BSC). We evaluated the feasibility of using 5-azacytidine (AZA)...
4.
Antony-Debre I, Duployez N, Bucci M, Geffroy S, Micol J, Renneville A, et al.
Leukemia
. 2015 Aug;
30(4):999-1002.
PMID: 26316320
No abstract available.
5.
Inoue D, Kitaura J, Matsui H, Hou H, Chou W, Nagamachi A, et al.
Leukemia
. 2014 Oct;
29(4):847-57.
PMID: 25306901
Mutations in ASXL1 are frequent in patients with myelodysplastic syndrome (MDS) and are associated with adverse survival, yet the molecular pathogenesis of ASXL1 mutations (ASXL1-MT) is not fully understood. Recently,...
6.
Rahme R, Thomas X, Recher C, Vey N, Delaunay J, Deconinck E, et al.
Leukemia
. 2014 Aug;
28(12):2422-4.
PMID: 25142818
No abstract available.
7.
Desplanques P, Burlacu R, Poinsignon V, Boussion H, Borget I, Wyplosz B, et al.
Med Mal Infect
. 2014 Mar;
44(4):174-9.
PMID: 24656841
Purpose: The effectiveness of posaconazole (PSZ) prophylaxis on invasive fungal infections, in patients presenting with acute myeloid leukemia (AML), seems to be correlated to its blood plasma concentration. Our goal...
8.
Micol J, Chahine C, Woerther P, Ghez D, Netzer F, Dufour C, et al.
Clin Microbiol Infect
. 2013 Dec;
20(7):O453-5.
PMID: 24313354
Based on recommendations of the ECIL-4, we prospectively evaluated discontinuation of empirical antibiotic therapy in high-risk neutropenic acute myeloid leukaemia patients with fever of unknown origin. Seven patients (median neutropenia...
9.
Marcade G, Micol J, Jacquier H, Raskine L, Donay J, Nicolas-Viaud S, et al.
J Antimicrob Chemother
. 2013 Oct;
69(2):500-5.
PMID: 24092659
Objectives: To report an outbreak due to an unusual strain of Enterococcus faecium containing both the vanA and vanB genes, in France, where the rate of glycopeptide-resistant enterococci (GRE) is...
10.
Lainey E, Wolfromm A, Marie N, Enot D, Scoazec M, Bouteloup C, et al.
Oncogene
. 2012 Oct;
32(37):4331-42.
PMID: 23085751
The term myelodysplastic syndrome (MDS) identifies a heterogeneous group of clonal disorders originating from bone marrow stem cells that often progress to acute myeloid leukemia (AML). The reference treatments for...